Skip to main content

Find Clinical Trials

Home
Conditions
Soluble Urokinase Plasminogen Activation Receptor

Clinical trial condition

Soluble Urokinase Plasminogen Activation Receptor

Explore clinical trials studying Soluble Urokinase Plasminogen Activation Receptor. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Soluble Urokinase Plasminogen Activation Receptor trial results

Completed

Prognostic Value of Soluble Urokinase Plasminogen Activation Receptor (SUPAR) to Rule Out Complications in Patients Admitted in Emergency Department for Acute Abdominal Pain.

NCT05580016

Conditions: Abdominal Pain, Disease Attributes, Emergencies, +9 more
Locations: CHU of Poitiers Poitiers, France

View Trial Details